dihydroxyphenylalanine has been researched along with alpha-synuclein in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Di Monte, DA; Fink, AL; Li, J; Manning-Bog, AB; Zhu, M | 1 |
| Asanuma, M; Chiba, T; Hattori, N; Ito, S; Iwatsubo, T; Jansen, PH; Koyama, A; Machida, Y; Mizuno, Y; Ogawa, N; Shimizu, N; Takayanagi, A; Tanaka, K; Tanaka, Y | 1 |
| Hattori, N; Machida, Y; Noda, K | 1 |
| Ebadi, M; Govitrapong, P; Klongpanichapak, S; Sharma, SK | 1 |
| Cambrea, LR; Haque, F; Hovis, JS; Rochet, JC; Schieler, JL | 1 |
| Chu, Y; Kordower, JH | 1 |
| Bisaglia, M; Bubacco, L; Cookson, MR; Greggio, E; Maric, D; Miller, DW | 1 |
| Goldstein, DS; Holmes, C; Park, MY; Sewell, L; Sharabi, Y | 1 |
| Bours, V; Caberg, JH; Dive, D; Garraux, G; Jamar, M; Moonen, G; Vanbellinghen, JF | 1 |
| Goldstein, DS; Holmes, C; Sharabi, Y; Wu, T | 1 |
| Braun, AR; Buchholz, CR; Nathan Kochen, N; Pandey, AK; Pomerantz, WCK; Sachs, JN | 1 |
| Fang, X; Li, H; Li, S; Lin, Q; Lu, C; Wang, X; Yang, H; Yu, A; Yu, Y; Yuan, M; Zhao, F | 1 |
1 review(s) available for dihydroxyphenylalanine and alpha-synuclein
| Article | Year |
|---|---|
Lewy body pathology in fetal grafts.
Topics: alpha-Synuclein; Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Female; Fetal Tissue Transplantation; Fetus; Fluorine Radioisotopes; Graft Survival; Humans; Isotope Labeling; Lewy Bodies; Melanins; Pregnancy; Substantia Nigra | 2010 |
11 other study(ies) available for dihydroxyphenylalanine and alpha-synuclein
| Article | Year |
|---|---|
Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Brain; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Epinephrine; Humans; Mice; Microscopy, Atomic Force; Nerve Tissue Proteins; Oxidation-Reduction; Parkinson Disease; Protein Structure, Quaternary; Synucleins | 2004 |
Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
Topics: alpha-Synuclein; Apoptosis; Caspases; Cell Line, Tumor; Cell Survival; Dihydroxyphenylalanine; Dopamine; HeLa Cells; Humans; Nerve Tissue Proteins; Neuroblastoma; Parkinson Disease; Synucleins; Ubiquitin-Protein Ligases | 2005 |
[Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].
Topics: alpha-Synuclein; Animals; Apoptosis; Cells, Cultured; Dihydroxyphenylalanine; Dopamine; Humans; I-kappa B Proteins; Lewy Bodies; NF-KappaB Inhibitor alpha; Parkinson Disease; Phosphorylation; Ubiquitin-Protein Ligases | 2005 |
Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.
Topics: alpha-Synuclein; Animals; Central Nervous System Stimulants; Cocaine; Coenzymes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Electron Transport Complex I; Immunoblotting; Lipid Peroxidation; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microdialysis; Reactive Oxygen Species; Tyrosine 3-Monooxygenase; Ubiquinone | 2006 |
Effect of ions on the organization of phosphatidylcholine/phosphatidic acid bilayers.
Topics: alpha-Synuclein; Dihydroxyphenylalanine; Escherichia coli; Fluorescence Recovery After Photobleaching; Ions; Lipid Bilayers; Lipids; Microscopy, Fluorescence; Phosphatidic Acids; Phosphatidylcholines; Protein Structure, Tertiary; Spectroscopy, Fourier Transform Infrared; Static Electricity; Time Factors | 2007 |
Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells.
Topics: alpha-Synuclein; Apoptosis; Cell Death; Cell Line, Tumor; Cell Survival; Dihydroxyphenylalanine; Dopamine; Fluorescence; Humans; L-Lactate Dehydrogenase; Mutation, Missense; Necrosis; Neuroblastoma; Neurons; Parkinson Disease; Transfection | 2010 |
Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.
Topics: Aged; alpha-Synuclein; Autonomic Denervation; Dementia; Dihydroxyphenylalanine; Disease Progression; Dopamine; Dopaminergic Neurons; Gait Disorders, Neurologic; Hallucinations; Humans; Lewy Body Disease; Male; Neostriatum; Norepinephrine; Parkinson Disease; Radiopharmaceuticals; Shy-Drager Syndrome; Sympathetic Nervous System | 2012 |
Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism.
Topics: Adult; Age of Onset; alpha-Synuclein; Antiparkinson Agents; Chromosomes, Human, Pair 4; Dihydroxyphenylalanine; Dopamine Agonists; Female; Gene Duplication; Humans; Intellectual Disability; Karyotyping; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Trisomy | 2012 |
Survival in synucleinopathies: A prospective cohort study.
Topics: Aged; alpha-Synuclein; Brain; Cerebellar Diseases; Cohort Studies; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Longitudinal Studies; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Proportional Hazards Models; Prospective Studies; Pure Autonomic Failure; Radionuclide Imaging | 2015 |
pH Effects Can Dominate Chemical Shift Perturbations in
Topics: alpha-Synuclein; Dihydroxyphenylalanine; Hydrogen-Ion Concentration; Nuclear Magnetic Resonance, Biomolecular; Small Molecule Libraries | 2023 |
In situ continuous Dopa supply by responsive artificial enzyme for the treatment of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Dihydroxyphenylalanine; Dopamine; Mice; Nucleic Acids; Parkinson Disease | 2023 |